Drug
Fianlimab Cemiplimab
Fianlimab Cemiplimab: highest development phase Phase 2, developed by Regeneron. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Regeneron
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fianlimab+cemiplimab NCT06848088 | Phase 2 | Melanoma |
Latest
No recent events.
Follow Fianlimab Cemiplimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.